TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33103379

Group type: COMPARATOR
Intervention: HBex (blended home-based exercise intervention)
Number of subjects: 245

Group type: COMPARATOR
Intervention: HBex-Pro (blended home-based exercise with dietary protein counselling)
Number of subjects: 245

Group type: COMPARATOR
Intervention: HBex-Pro
Number of subjects: 245

Group type: COMPARATOR
Intervention: HBex, HBex-Pro
Number of subjects: 245
Study: 33992238

Group type: EXPERIMENTAL
Intervention: Peripheral dry needling (PDN)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Spinal and peripheral dry needling (SPDN)
Number of subjects: 34
Study: 36417043

Group type: EXPERIMENTAL
Intervention: Cancellous bone chips from iliac crest (Group A)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Cortical bone chips harvested from maxilla using a curved bone scraper, covered with PRF (Group B)
Number of subjects: 72
Study: 33124098

Group type: EXPERIMENTAL
Intervention: Micro-osteoperforations (MOPs)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Piezocision (Piezo)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (conventional treatment)
Number of subjects: 24
Study: 35351158

Group type: EXPERIMENTAL
Intervention: Augmented reality navigation system
Number of subjects: 22

Group type: COMPARATOR
Intervention: Traditional optical navigation
Number of subjects: 22
Study: 34825770

Group type: EXPERIMENTAL
Intervention: Intralesional steroid with QR678 Neo®
Number of subjects: 20

Group type: COMPARATOR
Intervention: Intralesional steroid alone
Number of subjects: 20
Study: 32571718

Group type: EXPERIMENTAL
Intervention: Agriflu®
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Fluzone®
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Fluarix®
Number of subjects: 183

Group type: COMPARATOR
Intervention: Control (non-pregnant women)
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: All IIV3s
Number of subjects: 183
Study: 34344416

Group type: EXPERIMENTAL
Intervention: Higher soluble thrombomodulin (sTM) levels
Number of subjects: 432

Group type: EXPERIMENTAL
Intervention: Initial and slope of sTM levels
Number of subjects: 432
Study: 32390540

Group type: EXPERIMENTAL
Intervention: Medical education curriculum
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Years of experience
Number of subjects: 12
Study: 35940251

Group type: EXPERIMENTAL
Intervention: 5-hydroxytryptophan (100 mg oral, twice daily for 8 weeks)
Number of subjects: 166

Group type: COMPARATOR
Intervention: Placebo (twice daily for 8 weeks)
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: 5-hydroxytryptophan
Number of subjects: 166

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 166
Study: 33602684

Group type: EXPERIMENTAL
Intervention: Inotuzumab ozogamicin
Number of subjects: 326

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 326
Study: 32701419

Group type: EXPERIMENTAL
Intervention: TAU + TES (n=48, analyzed = 41)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Treatment as usual (TAU, n=47)
Number of subjects: 95
Study: 36227604

Group type: EXPERIMENTAL
Intervention: Oxaliplatin and fluorouracil/leucovorin (MOSAIC trial)
Number of subjects: 3186

Group type: COMPARATOR
Intervention: Modified FOLFOX-6 regimen (US Oncology)
Number of subjects: 3186
Study: 34153143

Group type: EXPERIMENTAL
Intervention: Clazakizumab (anti-IL-6 antibody)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 32239786

Group type: EXPERIMENTAL
Intervention: Endotracheal tube (ETT) insertion depth based on birth weight
Number of subjects: 40

Group type: COMPARATOR
Intervention: Gestational age for estimating ETT insertion depth
Number of subjects: 40
Study: 34238555

Group type: EXPERIMENTAL
Intervention: Firesorb BRS
Number of subjects: 433

Group type: COMPARATOR
Intervention: CoCr-EES
Number of subjects: 433
Study: 35195306

Group type: EXPERIMENTAL
Intervention: Oral 50 mg Zoledronic acid (ZA) once-a-week for 6 weeks
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 34420816

Group type: EXPERIMENTAL
Intervention: Saxagliptin 5 mg a day
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 32277937

Group type: EXPERIMENTAL
Intervention: Cone-beam computed tomography (CBCT)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Panoramic radiography (OPG)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: CBCT
Number of subjects: 71

Group type: COMPARATOR
Intervention: OPG
Number of subjects: 71
Study: 35525971

Group type: EXPERIMENTAL
Intervention: Tai Chi
Number of subjects: 238
Study: 32465404

Group type: EXPERIMENTAL
Intervention: CNI-free, everolimus (EVR)-based immunosuppression
Number of subjects: 12
Study: 36282834

Group type: EXPERIMENTAL
Intervention: Minor Ailment Service (MAS)
Number of subjects: 808

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 808
Study: 32453274

Group type: EXPERIMENTAL
Intervention: Decision support intervention
Number of subjects: 30

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 30
Study: 36287389

Group type: EXPERIMENTAL
Intervention: 1.5 mg/kg 1% lidocaine (0.15 ml/kg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: 0.15 ml/kg 0.9% NaCl (placebo)
Number of subjects: 60
Study: 32660264

Group type: EXPERIMENTAL
Intervention: Resistance training
Number of subjects: 40
Study: 35596730

Group type: EXPERIMENTAL
Intervention: LA-cookie (10 g grapeseed oil per day)
Number of subjects: 84

Group type: COMPARATOR
Intervention: OA-cookie (10 g high oleate safflower oil per day)
Number of subjects: 84
Study: 34310352

Group type: EXPERIMENTAL
Intervention: Swabs containing tea tree oil and chamomile oil
Number of subjects: 49

Group type: COMPARATOR
Intervention: Baby Shampoo (BS)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Both treatments (swabs and BS)
Number of subjects: 49
Study: 32719258

Group type: EXPERIMENTAL
Intervention: Simultaneous integrated boost (SIB)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Sequential boost (SEQB)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 24
Study: 35120436

Group type: EXPERIMENTAL
Intervention: Prolonged balloon inflation in stent deployment (PBSG)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional deployment strategy (CDSG)
Number of subjects: 0
Study: 33212063

Group type: EXPERIMENTAL
Intervention: Patisiran 0.3 mg/kg by intravenous infusion every 3 weeks
Number of subjects: 211

Group type: COMPARATOR
Intervention: APOLLO-placebo
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Patisiran (phase 2 OLE)
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: APOLLO-patisiran
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Phase 2 OLE patisiran
Number of subjects: 211
Study: 32947644

Group type: EXPERIMENTAL
Intervention: Genetic risk for Graves' disease
Number of subjects: 473818

Group type: EXPERIMENTAL
Intervention: Genetic risk for autoimmune thyroiditis
Number of subjects: 473818

Group type: EXPERIMENTAL
Intervention: Genetic risk for hyperthyroidism
Number of subjects: 473818

Group type: EXPERIMENTAL
Intervention: Genetic risk for hyperthyroid conditions
Number of subjects: 473818
Study: 36027510

Group type: EXPERIMENTAL
Intervention: Renal Denervation (RDN)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Sham Control
Number of subjects: 80
Study: 34360151

Group type: EXPERIMENTAL
Intervention: Intervention group (IG) - walked to self-selected music with a predetermined tempo and received a behavioural change support programme
Number of subjects: 37

Group type: COMPARATOR
Intervention: Usual care group (UC)
Number of subjects: 37
Study: 35266158

Group type: EXPERIMENTAL
Intervention: Bamboo grass (Tiliacora triandra, Diels) pellet supplementation at 0, 1, 2, 3, and 4% of dry matter substrate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: R:C ratio at 30:70 with BP supplementation at 4%
Number of subjects: 0
Study: 32470918

Group type: EXPERIMENTAL
Intervention: Outdoor fitness equipment (OFE) training for 12 weeks
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group maintaining previous lifestyles
Number of subjects: 42
Study: 36380087

Group type: EXPERIMENTAL
Intervention: Placebo condition (inert electrical device with positive verbal information)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control condition (inert electrical device with neutral verbal information)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Placebo condition
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 24
Study: 33297773

Group type: EXPERIMENTAL
Intervention: PCV13 at priming and PHiD-CV at boosting (PPS)
Number of subjects: 294

Group type: EXPERIMENTAL
Intervention: PCV13 then PHiD-CV at priming and PHiD-CV at boosting (PSS)
Number of subjects: 294

Group type: COMPARATOR
Intervention: PHiD-CV at priming and boosting (SSS control)
Number of subjects: 294

Group type: EXPERIMENTAL
Intervention: Mixed regimens (PPS and PSS)
Number of subjects: 294

Group type: COMPARATOR
Intervention: PHiD-CV only
Number of subjects: 294
Study: 33184861

Group type: EXPERIMENTAL
Intervention: Revised process recording (self-compassion)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 35
Study: 32323052

Group type: EXPERIMENTAL
Intervention: Televised football match highlights containing a high density of embedded promotion
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Amateur football match highlights containing no gambling-related cues or embedded promotion
Number of subjects: 60

Group type: COMPARATOR
Intervention: Neutral control video containing footage of a live concert
Number of subjects: 60
Study: 33730524

Group type: EXPERIMENTAL
Intervention: Monofocal intraocular lenses
Number of subjects: 29

Group type: COMPARATOR
Intervention: Multifocal intraocular lenses
Number of subjects: 29
Study: 33065589

Group type: EXPERIMENTAL
Intervention: Delayed-Release Linaclotide 30 μg
Number of subjects: 532

Group type: EXPERIMENTAL
Intervention: Delayed-Release Linaclotide 100 μg
Number of subjects: 532

Group type: EXPERIMENTAL
Intervention: Delayed-Release Linaclotide 300 μg
Number of subjects: 532

Group type: EXPERIMENTAL
Intervention: MD-7246 (formerly DR2) 30 μg
Number of subjects: 532

Group type: EXPERIMENTAL
Intervention: MD-7246 (formerly DR2) 100 μg
Number of subjects: 532

Group type: EXPERIMENTAL
Intervention: MD-7246 (formerly DR2) 300 μg
Number of subjects: 532

Group type: EXPERIMENTAL
Intervention: Immediate-Release Linaclotide 290 μg
Number of subjects: 532

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 532
Study: 34151828

Group type: EXPERIMENTAL
Intervention: Conventional feedback (verbal and tactile)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Visual feedback (real-time ultrasound images)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 180
Study: 34078268

Group type: EXPERIMENTAL
Intervention: Diffusion tensor imaging (DTI) measurements related to the superior longitudinal fasciculus (SLF) and Anorexia nervosa (AN)
Number of subjects: 17706

Group type: EXPERIMENTAL
Intervention: Diffusion tensor imaging (DTI) measurements related to the body of the corpus callosum and Alzheimer's disease
Number of subjects: 17706

Group type: EXPERIMENTAL
Intervention: Overall DTI - Disorder associations
Number of subjects: 17706

Group type: EXPERIMENTAL
Intervention: Diffusion tensor imaging (DTI) measurements related to Bipolar disorder (BP)
Number of subjects: 17706

Group type: EXPERIMENTAL
Intervention: Diffusion tensor imaging (DTI) measurements related to Anorexia nervosa (AN)
Number of subjects: 17706

Group type: EXPERIMENTAL
Intervention: Region-of-interest (ROI) analysis related to the brain region of pars triangularis and Schizophrenia
Number of subjects: 17706

Group type: EXPERIMENTAL
Intervention: Overall ROI - Disorder analysis
Number of subjects: 17706
Study: 35160076

Group type: EXPERIMENTAL
Intervention: 200 mL of 20% albumin administered after induction of anesthesia
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (no albumin administration)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Albumin group
Number of subjects: 200
Study: 32429851

Group type: EXPERIMENTAL
Intervention: Galcanezumab 240 mg
Number of subjects: 477

Group type: EXPERIMENTAL
Intervention: Galcanezumab 120 mg
Number of subjects: 477

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 477

Group type: EXPERIMENTAL
Intervention: Galcanezumab (both doses combined)
Number of subjects: 477

Group type: EXPERIMENTAL
Intervention: Galcanezumab
Number of subjects: 477
Study: 32338316

Group type: EXPERIMENTAL
Intervention: Transdermal granisetron (granisetron patch replaced every 7 days)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Oral ondansetron (8 mg thrice daily for 72 hours after chemotherapy)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Transdermal granisetron
Number of subjects: 75

Group type: COMPARATOR
Intervention: Oral ondansetron
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Transdermal granisetron and Oral ondansetron
Number of subjects: 75
Study: 35785794

Group type: COMPARATOR
Intervention: Children without SCA (HbAA)
Number of subjects: 3483

Group type: EXPERIMENTAL
Intervention: Children with known SCA
Number of subjects: 3483

Group type: EXPERIMENTAL
Intervention: Children with unknown SCA
Number of subjects: 3483

Group type: EXPERIMENTAL
Intervention: Children with SCA (both known and unknown)
Number of subjects: 3483

Group type: EXPERIMENTAL
Intervention: Children with SCA
Number of subjects: 3483
Study: 34280468

Group type: EXPERIMENTAL
Intervention: Basal insulin plus GLP-1RA
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Basal insulin plus daily gliflozin pill
Number of subjects: 0
Study: 34534029

Group type: EXPERIMENTAL
Intervention: Expressive writing about a retrospective cheerful scenario
Number of subjects: 933

Group type: EXPERIMENTAL
Intervention: Expressive writing about a retrospective serious scenario
Number of subjects: 933

Group type: EXPERIMENTAL
Intervention: Expressive writing about a retrospective bad mood scenario
Number of subjects: 933

Group type: EXPERIMENTAL
Intervention: Short version of the State-Trait Cheerfulness Inventory (STCI-S)
Number of subjects: 933

Group type: EXPERIMENTAL
Intervention: Standard version of the State-Trait Cheerfulness Inventory (STCI-S)
Number of subjects: 933

Group type: EXPERIMENTAL
Intervention: Self-report state measures (inspiration, self-esteem, depression, anxiety)
Number of subjects: 933
Study: 32844320

Group type: EXPERIMENTAL
Intervention: Brain CT scans performed without meeting the criteria of any of the standardized guidelines.
Number of subjects: 170
Study: 34237311

Group type: EXPERIMENTAL
Intervention: Concord grape juice (CGJ)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 33687988

Group type: EXPERIMENTAL
Intervention: Flexible subcutaneous catheter
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard needles
Number of subjects: 20
Study: 32808209

Group type: EXPERIMENTAL
Intervention: Lifestyle habits including consumption of low-fat foods, fish, desserts, sugary beverages, fruits, and vegetables; moderate-vigorous physical activity; steps recorded by a pedometer; sedentary behavior
Number of subjects: 178
Study: 35538144

Group type: EXPERIMENTAL
Intervention: Cricket-derived protein (25g)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Beef-derived protein (25g)
Number of subjects: 20
Study: 33314016

Group type: EXPERIMENTAL
Intervention: Virtual reality therapy (VRT) Armeo Spring® upper limb exoskeleton (Armeo), 45 minutes daily for 3 weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional physiotherapy, 45 minutes daily for 3 weeks
Number of subjects: 50
Study: 35197360

Group type: EXPERIMENTAL
Intervention: Aducanumab (30 mg/kg single dose)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aducanumab (3-10 mg/kg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aducanumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 36112019

Group type: EXPERIMENTAL
Intervention: Doxycycline hyclate injected at the implant-abutment interface
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 20
Study: 32634064

Group type: EXPERIMENTAL
Intervention: Staples
Number of subjects: 535

Group type: COMPARATOR
Intervention: Sutures
Number of subjects: 535
Study: 36398746

Group type: EXPERIMENTAL
Intervention: Muscle Shortening Maneuver (MSM), n=5
Number of subjects: 10

Group type: COMPARATOR
Intervention: Conventional Physical Therapy (CPT), n=5
Number of subjects: 10
Study: 32603408

Group type: EXPERIMENTAL
Intervention: Lyophilized Nile Tilapia Skin (LNTS)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Silver-impregnated sodium carboxymethylcellulose dressing
Number of subjects: 24
Study: 32736660

Group type: EXPERIMENTAL
Intervention: Video DOT delivered via a smartphone app
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment-as-usual (control)
Number of subjects: 0
Study: 34605959

Group type: EXPERIMENTAL
Intervention: Yohimbine (alpha2-receptor blocker)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: MDD patients
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: ACE
Number of subjects: 128
Study: 33068366

Group type: EXPERIMENTAL
Intervention: Herbal cleanser containing Acanthus ebracteatus Vahl., Suregada multiflora, and Acacia concinna
Number of subjects: 30

Group type: COMPARATOR
Intervention: Vehicle-controlled cleanser
Number of subjects: 30
Study: 33895431

Group type: EXPERIMENTAL
Intervention: Guided graded exercise self-help (GES)
Number of subjects: 211

Group type: COMPARATOR
Intervention: Specialist medical care (SMC)
Number of subjects: 211
Study: 33167907

Group type: EXPERIMENTAL
Intervention: Military-Civilian Adjustment and Reintegration Measure (M-CARM)
Number of subjects: 725
Study: 35806857

Group type: EXPERIMENTAL
Intervention: 3.6 g sodium butyrate daily for 12 weeks
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study: 34051877

Group type: EXPERIMENTAL
Intervention: Colchicine (0.5 mg twice per day for 3 days, then once per day for 27 days)
Number of subjects: 4488

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4488

Group type: EXPERIMENTAL
Intervention: Colchicine (among PCR-confirmed COVID-19 patients)
Number of subjects: 4488

Group type: COMPARATOR
Intervention: Placebo (among PCR-confirmed COVID-19 patients)
Number of subjects: 4488

Group type: EXPERIMENTAL
Intervention: Colchicine
Number of subjects: 4488
Study: 33331570

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (Dex) treatment during surgery
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (Dex) treatment
Number of subjects: 86

Group type: COMPARATOR
Intervention: Routine anesthesia (Control)
Number of subjects: 86
Study: 35442064

Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 0
Study: 33749349

Group type: EXPERIMENTAL
Intervention: Rehabilitation program (n=30)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Standard care control (n=28)
Number of subjects: 117
Study: 32092167

Group type: EXPERIMENTAL
Intervention: Pulse-based diet (lentils, beans, split peas and chickpeas)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Therapeutic Lifestyle Changes (TLC) diet
Number of subjects: 61
Study: 33484625

Group type: EXPERIMENTAL
Intervention: HK$0 fee group
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: HK$150 fee group
Number of subjects: 239

Group type: COMPARATOR
Intervention: HK$300 fee group
Number of subjects: 239
Study: 32650345

Group type: EXPERIMENTAL
Intervention: Polypectomy Efficiency (PE)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Neoplastic Polypectomy Efficiency (NPE)
Number of subjects: 20
Study: 34890047

Group type: COMPARATOR
Intervention: Clomiphene Citrate (CC) 100 mg/day
Number of subjects: 501

Group type: COMPARATOR
Intervention: Letrozole (L) 5 mg/day
Number of subjects: 501

Group type: EXPERIMENTAL
Intervention: Letrozole (L) 2.5 mg/day + Clomiphene Citrate (CC) 50 mg/day
Number of subjects: 501
Study: 34886482

Group type: EXPERIMENTAL
Intervention: Ai-Chi practice
Number of subjects: 19

Group type: COMPARATOR
Intervention: Structured on-land Ai-Chi practice
Number of subjects: 19

Group type: COMPARATOR
Intervention: Guided-imagery of Ai-Chi practice
Number of subjects: 19
Study: 32125110

Group type: EXPERIMENTAL
Intervention: Combined individual-collective debriefing
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard collective debriefing
Number of subjects: 30
Study: 35274407

Group type: EXPERIMENTAL
Intervention: D‐MCT (Metacognitive Training for Depression)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Euthymic therapy (active control)
Number of subjects: 75
Study: 34354699

Group type: EXPERIMENTAL
Intervention: Multidrug therapy (MDT) comprising rifampicin, dapsone, and clofazimine, 12 doses
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multidrug therapy (MDT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CXCL10 (IP‐10)
Number of subjects: 0
Study: 32151918

Group type: EXPERIMENTAL
Intervention: 12-week exercise program combining weekly group sessions and home-based exercises (2/week) focusing on motor learning, flexibility, strengthening, and balance.
Number of subjects: 210

Group type: COMPARATOR
Intervention: Placebo ultrasound given once a week.
Number of subjects: 210

Group type: COMPARATOR
Intervention: Non-treated control group.
Number of subjects: 210
Study: 35525784

Group type: EXPERIMENTAL
Intervention: Social-physical activity program (2 weekly sessions of 1 hour of physical exercise for 4 months; monthly sessions on healthy habits; 3 days of social activities)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Usual advice (Control group)
Number of subjects: 102
Study: 33301362

Group type: EXPERIMENTAL
Intervention: Remote monitoring (RM) with appropriate contacts to FTC alerts
Number of subjects: 505

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 505
Study: 35750597

Group type: EXPERIMENTAL
Intervention: Combined anterior and posterior ring (APR) fixation
Number of subjects: 40

Group type: COMPARATOR
Intervention: Isolated posterior ring (PR) fixation
Number of subjects: 40
Study: 33891718

Group type: EXPERIMENTAL
Intervention: Brief Family Intervention (BFI)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (no BFI)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both conditions (BFI and Control)
Number of subjects: 40
Study: 32960889

Group type: EXPERIMENTAL
Intervention: SRP+Probiotic (Bifidobacterium animalis subsp. lactis HN019)
Number of subjects: 30

Group type: COMPARATOR
Intervention: SRP+Placebo
Number of subjects: 30
Study: 35670065

Group type: EXPERIMENTAL
Intervention: Intermittent theta-burst stimulation (iTBS)
Number of subjects: 50